General Information of the Compound
| Compound ID |
CP0393991
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,3S,4R)-5-[6-[[4-[bis(prop-2-enyl)sulfamoyl]phenyl]carbamoylamino]purin-9-yl]-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H30N8O7S
|
||||||||||||||||||
| Molecular Weight |
586.631
|
||||||||||||||||||
| Canonical SMILES |
CCNC(=O)[C@H]1OC([C@H](O)[C@@H]1O)n1cnc2c(NC(=O)Nc3ccc(cc3)S(=O)(=O)N(CC=C)CC=C)ncnc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H30N8O7S/c1-4-11-32(12-5-2)41(38,39)16-9-7-15(8-10-16)30-25(37)31-21-17-22(28-13-27-21)33(14-29-17)24-19(35)18(34)20(40-24)23(36)26-6-3/h4-5,7-10,13-14,18-20,24,34-35H,1-2,6,11-12H2,3H3,(H,26,36)(H2,27,28,30,31,37)/t18-,19+,20-,24?/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XSBIOWQBSLLZLW-PHTWQSKTSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01279, Adenosine receptor A3